Pattern Bioscience has surpassed 1,000 samples in our multi-center U.S. clinical trial of a rapid, direct-from-specimen pneumonia ID/AST panel, marking the halfway point of the study designed to support our FDA 510(k) submission.

Learn more: pattern.bio/pattern-biosci…

Pattern Bioscience has surpassed 1,000 samples in our multi-center U.S. clinical trial of a rapid, direct-from-specimen pneumonia ID/AST panel, marking the halfway point of the study designed to support our FDA 510(k) submission.

Learn more: pattern.bio/pattern-biosci…

Today we announced a $43M Series D raise to advance our mission to transform bacterial infection diagnosis & treatment by supporting a US clinical trial & FDA clearance for our rapid Pneumonia ID/AST Panel.

More details: bit.ly/480r36m

A huge thank you to everyone who visited our booth, attended our Spotlight Talk, and explored our posters at #ASMicrobe 2025!

We appreciated the opportunity to share our single-cell platform and to connect with those working to move infectious disease diagnostics forward.

We're bringing the science to center stage at #ASMicrobe 2025 in LA.

Join us throughout for discussions, poster presentations, & live demos at Booth #2131 as we showcase how our single-cell microbiology platform can reshape clinical microbiology.

We're heading to #ASMicrobe 2025 in LA!

Catch us at Booth #2131 to see how our single-cell microbiology platform will transform infectious disease diagnostics with faster screening, ID and AST results.

Thanks to everyone who stopped by our poster at #ESCMIDGlobal today! Great to connect and share our latest preclinical data—highlighting excellent direct-from-specimen ID/AST performance.

Thrilled to join experts at #ESCMIDGlobal to explore the latest in #InfectiousDiseases & clinical microbiology!

We'll present new data from a preclinical study, showcasing excellent phenotypic ID/AST performance from complex, polymicrobial lower respiratory specimens.

Important leadership news at Pattern:

Carey-Ann Burnham, our chief clinical officer since 2022, is now CEO! Founder Nick Arab transitions to CTO, focusing on advancing our single-cell microbiology tech.

More details: pattern.bio/pattern-biosci…

We are partnering with @Patternbio to develop a system for rapid identification & phenotypic antimicrobial susceptibility testing (ID/AST), which can measure which antibiotics are effective against specific bacteria. Learn more: ow.ly/vxq750UaRke

We’re pleased to announce a partnership with @BARDA to support the late-stage development, verification, validation, and FDA clearance of our single-cell microbiology system and ID/AST testing panels.

Partnership details: pattern.bio/pattern-awarde…

Day 2 of our exhibition at #ASMicrobe is underway, and we’re energized by the connections from Day 1.

Want to learn more about our award-winning single-cell microbiology testing platform? Drop by booth #825 for a live demo and chat with our team.

Interested in our cutting-edge single-cell microbiology technology? Join @BurnhamBugDoc this Friday at 5:15pm at #ASMicrobe for a spotlight discussion on our award-winning innovation.

Get ready to explore the future of microbiology with us at #ASMicrobe this week in Atlanta. Catch us at one of our presentations or in booth #825 to see a demo of our single-cell microbiology system.

Join us at #ASMicrobe 2024 to explore the future of microbiology. Discover our single-cell microbiology technology—an award-winning innovation poised to enable same-day, precise antibiotic treatment.

See you soon, Atlanta!

Looking for an overview on how we’re tackling #AntibioticResistance with our award-winning single-cell microbiology technology? @myADLM has you covered:

Article 🔗: myadlm.org/cln/articles/2…

A vicious cycle of diagnostic uncertainty, antibiotic misuse, and antibiotic resistance fuels the spread of drug-resistant infections.

Our solution: break the cycle by providing same-day diagnostic certainty for targeted treatment.

#WAAW23 #AMR

There’s currently no diagnosis method for #Pneumonia that is rapid and definitive.

Time is life and death for patients and we believe that a rapid antibiotic susceptibility test for pneumonia will make a real difference in the fight against this deadly disease.#WorldPneumoniaDay

Join us as we recognize and celebrate #InfectionPrevention professionals for the work they do to keep our communities safe by preventing the spread of #SuperBugs.

#IIPW23

We’re thrilled to welcome Tim Skansi and Travis Davies to our #Leadership team. Tim and Travis will play key roles in helping us achieve our mission of setting a new standard in #InfectiousDisease diagnosis.

Full PR: pattern.bio/pattern-biosci…